- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.05. | Genentech gains FDA approval for diabetic retinopathy treatment | ||
| 22.05. | Juvenescence secures $76m funding to advance therapeutic pipeline | ||
| 21.05. | Mirai Bio and Thermo Fisher to advance genetic medicine development | ||
| 20.05. | FDA grants fast track status to Zai Lab's lung cancer treatment | ||
| 19.05. | Canadian research initiative secures grant for paediatric brain cancer | ||
| 16.05. | FDA grants RMAT to BrainChild Bio's CAR T-cell therapy for DIPG | ||
| 15.05. | AbbVie and ADARx to develop siRNA therapeutics for multiple disease areas | ||
| 14.05. | FDA to review Regenxbio's gene therapy BLA for Hunter syndrome | ||
| 13.05. | InnoCare's Mesutoclax obtains breakthrough therapy designation in China | ||
| 12.05. | Sirius secures $50m to advance siRNA therapeutics for cardiometabolic disorders | ||
| 09.05. | MIRA secures board approval to buy SKNY Pharmaceuticals | ||
| 08.05. | Evotec secures $2.5m grant for TB treatment development | ||
| 07.05. | FDA grants fast track status to Alterity's multiple system atrophy treatment | ||
| 06.05. | USPTO grants two additional patents to Moleculin's drug candidate | ||
| 05.05. | PCI completes acquisition of sterile fill-finish CDMO Ajinomoto Althea | ||
| 02.05. | CHMP endorses Roche's breast cancer therapy for administration out of clinical settings | ||
| 01.05. | Er-Kim to distribute Puma's Nerlynx in Central Asian, Eastern European countries | ||
| 30.04. | Abeona announces FDA approval for cell-based gene therapy for RDEB patients | ||
| 29.04. | EMA grants orphan drug status to Purespring's IgA nephropathy treatment | ||
| 28.04. | Apnimed acquires rights to sleep apnoea treatment from Desitin Arzneimittel | ||
| 25.04. | Tempus AI, AstraZeneca, and Pathos AI join forces on cancer care | ||
| 24.04. | NICE issues final guidance endorsing Pharming's APDS therapy | ||
| 23.04. | Ensem Therapeutics' application for ETX-636 secures FDA clearance | ||
| 22.04. | Viatris files applications in Japan for approval of Effexor to treat GAD | ||
| 21.04. | US FDA clears Calidi's CLD-201 for clinical development in solid tumours |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .